Butylpyrazolidines

No definition available.

Endpoint definition

FinnGen phenotype data
diagram bullet diagram downward connector

Filter registries KELA purch., KELA reimb.

Medicine purchases: ATC M01AA
Medicine purchases: ATC: other data required >3 instances required

Check pre-conditions None

Include endpoints None

Check conditions None

Apply sex-specific rule None

diagram downward connector RX_BUTYLPYRA

Extra metadata

First used in FinnGen datafreeze DF4

Summary Statistics

Key figures

All Female Male
Number of individuals 9 - 6
Unadjusted prevalence (%) 0.00 - 0.01
Mean age at first event (years) 46.94 - 52.30

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Correlations

Index endpoint: RX_BUTYLPYRA – Butylpyrazolidines
GWS hits:

Survival analyses between endpoints

Plot

before Butylpyrazolidines
after Butylpyrazolidines

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Butylpyrazolidines